Give me mbbs level Knowledge on anxiety

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Loading Image

I now have all the material needed. Here is the comprehensive MBBS-level knowledge on Anxiety:

Anxiety Disorders - MBBS Level

1. Definition and Normal vs. Pathological Anxiety

Fear is an expected emotional response to a real or perceived immediate threat. Anxiety is the anticipation of future danger - it is forward-looking and often without a clearly identifiable external stimulus.

Anxiety becomes a disorder when it is:

Excessive and out of proportion to the actual threat
Difficult or impossible to control
Persistent (lasting weeks to months)
Causes significant distress or impairment in social, occupational, or other functioning
Kaplan and Sadock's Synopsis of Psychiatry, p. 1249

2. Classification (DSM-5)

DSM-5 groups anxiety disorders separately from OCD and PTSD (which now have their own chapters). The main anxiety disorders are:

Disorder	Core Feature
Separation Anxiety Disorder	Excessive fear of separation from attachment figures
Selective Mutism	Failure to speak in specific social situations
Specific Phobia	Fear/avoidance of a specific object or situation
Social Anxiety Disorder (Social Phobia)	Fear of embarrassment or scrutiny in social situations
Panic Disorder	Recurrent unexpected panic attacks + anticipatory anxiety
Agoraphobia	Fear/avoidance of situations where escape is difficult
Generalized Anxiety Disorder (GAD)	Excessive, uncontrollable worry about multiple domains for ≥6 months
Substance/Medication-Induced Anxiety Disorder	Due to intoxication or withdrawal
Anxiety Disorder Due to Another Medical Condition	Secondary cause

Note: OCD, PTSD/Acute Stress Disorder, and adjustment disorders are no longer classified as anxiety disorders in DSM-5 - they have separate chapters.

3. Neurobiology of Anxiety

3a. The Amygdala - Center of Fear

The amygdala is an almond-shaped structure near the hippocampus that integrates sensory and cognitive information to determine whether a fear response is triggered.

Affect of Fear - Amygdala, ACC, and OFC overactivation producing fear

Key amygdala connections and outputs:

Prefrontal cortex (OFC + ACC) - regulates the feeling of fear
Periaqueductal gray (PAG) - mediates motor responses: fight, flight, or freeze
Hypothalamus / HPA axis - triggers cortisol release; chronic activation leads to CAD, T2DM, stroke risk, and hippocampal atrophy
Parabrachial nucleus - alters breathing (hyperventilation, dyspnea)
Autonomic nervous system - tachycardia, sweating, palpitations, mydriasis
Locus coeruleus - norepinephrine release

3b. CSTC Loops and Worry

The second core symptom - worry - is hypothetically linked to the Cortico-Striato-Thalamo-Cortical (CSTC) loop. This circuit underlies catastrophic thinking, apprehensive expectations, and obsessional worry seen in GAD.

3c. Key Neurochemical Systems

System	Brain Regions	Role in Anxiety
Serotonin (5-HT)	Dorsal raphe, amygdala, hippocampus, PFC	Low 5-HT1A activity in PD and SAD - target of SSRIs/SNRIs
Norepinephrine	Locus coeruleus, amygdala, hypothalamus	Unrestrained activation drives autonomic symptoms
GABA	Substantia nigra, globus pallidus, amygdala	Reduced GABA-A activity disinhibits fear circuits
Glutamate	Amygdala, hippocampus, frontal cortex	Imbalance with GABA drives excessive amygdala output
HPA / Cortisol	Hippocampus, amygdala, hypothalamus	Dysregulated cortisol feedback
Dopamine	Amygdala, nucleus accumbens, PFC	Excessive mesocortical dopamine release

Kaplan and Sadock's Synopsis of Psychiatry, p. 1267-1269
Stahl's Essential Psychopharmacology, p. 364-382

4. Specific Disorder Profiles

4a. Generalized Anxiety Disorder (GAD)

DSM-5 Criteria:

Excessive anxiety and worry about multiple events/activities, most days, for ≥6 months
Difficulty controlling the worry
At least 3 of 6 somatic symptoms:
1. Restlessness / feeling on edge
2. Easy fatigability
3. Difficulty concentrating / mind going blank
4. Irritability
5. Muscle tension
6. Sleep disturbance
Causes significant distress or impairment
Not attributable to substances or another medical condition

(In children, only 1 somatic symptom required)

Key feature: Worries span multiple domains (job, finances, health, family), cannot be prioritized or set aside, and catastrophe feels imminent.

Scales used: GAD-7, Beck Anxiety Inventory (BAI), Hamilton Anxiety Rating Scale (HAM-A), State-Trait Anxiety Inventory (STAI)

4b. Panic Disorder

Panic attack = discrete episode of intense fear with ≥4 symptoms peaking within minutes:

Palpitations/tachycardia
Sweating
Trembling/shaking
Shortness of breath/smothering
Choking sensation
Chest pain
Nausea/abdominal distress
Dizziness/lightheadedness
Derealization/depersonalization
Fear of losing control or "going crazy"
Fear of dying
Paresthesias
Chills or hot flushes

Panic Disorder DSM-5: Recurrent unexpected panic attacks + at least 1 month of:

Persistent concern/worry about future attacks ("anticipatory anxiety"), OR
Significant maladaptive change in behavior (avoidance)

Course: Onset typically late adolescence/early adulthood. Chronic but variable - ~30-40% become symptom-free long term; ~10-20% continue to have significant symptoms.

Agoraphobia often co-develops - avoidance of situations where escape is difficult (crowds, public transport, open spaces). It is now a separate diagnosis in DSM-5.

Kaplan and Sadock's Synopsis of Psychiatry, p. 1255

4c. Social Anxiety Disorder (Social Phobia)

Fear of social situations where one may be scrutinized or embarrassed
The fear is of embarrassment in the situation, not the situation itself (distinguishes it from specific phobia)
Marked avoidance or endurance with intense distress
Duration ≥6 months
Example: fear of public speaking, meeting new people, eating in public

4d. Specific Phobia

Persistent, intense, irrational fear of a specific object/situation
Specifiers: Animal, Natural environment, Blood-Injection-Injury (BII), Situational, Other
Exposure causes immediate fear/anxiety
Duration ≥6 months
BII subtype is notable: can cause vasovagal syncope (bradycardia, hypotension) rather than the typical sympathetic arousal

4e. Separation Anxiety Disorder

Developmentally inappropriate, excessive anxiety about separation from attachment figures
Requires ≥3 symptoms (refusal to go to school, nightmares about separation, somatic complaints on separation, persistent worry about harm coming to attachment figure)
Duration: ≥4 weeks in children, ≥6 months in adults (DSM-5 now applies to adults too)
Behaviorally inhibited children (high resting HR, elevated morning cortisol, low HRV) are at highest risk
Kaplan and Sadock's Synopsis of Psychiatry, p. 624-625

5. Epidemiology

Anxiety disorders are among the most common psychiatric conditions worldwide
Affect 10-20% of children and adolescents
Women are more commonly affected than men (approximately 2:1)
High comorbidity: among separation anxiety, GAD, and social anxiety disorder in youth, a child has a 60% chance of having at least one of the others; 30% have all three
High comorbidity with major depressive disorder (GAD and depression often co-occur; GAD may represent a prodromal or residual phase of depression)
Substance use disorder commonly co-occurs and worsens prognosis
Increased risk of suicide - must always be monitored

6. Differential Diagnosis

Medical causes to rule out:

Hyperthyroidism (anxiety, palpitations, tremor)
Pheochromocytoma (episodic hypertension, sweating, tachycardia)
Hypoglycemia
Cardiac arrhythmias
Seizure disorders (especially complex partial seizures)
Pulmonary embolism, asthma (dyspnea mimicking panic)
Cushing's disease (HPA dysregulation)
Drug withdrawal (alcohol, benzodiazepines, opioids)

Psychiatric differentiation:

Panic disorder vs. specific phobia: panic attacks in phobia are cued/expected (situational); in panic disorder they are unexpected
GAD vs. normal worry: GAD worry is excessive, uncontrollable, pervasive, and functionally impairing
Social anxiety vs. panic: social anxiety fear is of embarrassment/scrutiny; panic disorder fear is of the attack itself
OCD: obsessions cause anxiety but are ego-dystonic, intrusive, unwanted thoughts (separate category in DSM-5)

7. Treatment

7a. Pharmacotherapy

First-line for most anxiety disorders (GAD, Panic Disorder, Social Anxiety Disorder):

SSRIs - safest, best-tolerated, broadest efficacy (e.g., sertraline, escitalopram, paroxetine, fluoxetine)
SNRIs - venlafaxine, duloxetine; especially useful for GAD

Important note on SSRIs in panic disorder: May initially worsen panic attacks before improving them - start at low dose, warn the patient, and titrate slowly.

Drug Class	GAD	Panic Disorder	Social Anxiety
SSRIs	First line	First line	First line
SNRIs	First line	First line	First line
TCAs	Second line	Second line	Not recommended
MAOIs	Insufficient evidence	Second line	Second line
Benzodiazepines	Second line	Second line	Second line
Buspirone	Second line (GAD specific)	Second line	Second line
Pregabalin	Second line	Insufficient evidence	Second line
Quetiapine (atypical AP)	Second line	Insufficient	Not recommended
Beta-blockers (propranolol)	Only for performance anxiety	-	Performance anxiety only

Kaplan and Sadock's Synopsis of Psychiatry, p. 1258

Benzodiazepines (e.g., alprazolam, clonazepam, diazepam):

Mechanism: positive allosteric modulation of GABA-A receptors in the amygdala → reduces amygdala overactivation
Advantage: rapid onset (unlike SSRIs which take 2-4 weeks)
Disadvantages: dependence, withdrawal, cognitive dulling, abuse potential
Guidelines: mostly limit to short-term use or as adjunct to SSRIs during initiation phase
High-potency BZDs (alprazolam, clonazepam) preferred for panic disorder

Buspirone:

5-HT1A partial agonist
Effective for GAD specifically, requires chronic use (like SSRIs)
No dependence/withdrawal, no sedation, no abuse potential
Does not work for panic disorder or social anxiety

Pregabalin/Gabapentin (alpha-2-delta ligands):

Block presynaptic voltage-sensitive calcium channels → reduce glutamate release in the amygdala
Reduce both fear (amygdala) and worry (CSTC loops)
Stahl's Essential Psychopharmacology, p. 366-382

7b. Psychotherapy

Cognitive-Behavioral Therapy (CBT):

Most evidence-based psychotherapy for all anxiety disorders
Substantial effect for GAD, panic disorder, and social anxiety disorder
Components: psychoeducation, cognitive restructuring, behavioral exposure
For panic disorder: corrects false belief that mild bodily sensations signal impending doom/death
For social anxiety: individual or group CBT; considered first-line by some guidelines

Exposure Therapy:

In vivo exposure = treatment of choice for specific phobia
Systematic desensitization for phobias
Improves agoraphobia alongside panic treatment

Behavioral Therapy for agoraphobia: Rapid and complete reduction of avoidance behaviors.

Interpersonal Therapy (IPT): Also supported for anxiety disorders.

Combined treatment (pharmacotherapy + CBT): Generally superior to either alone, though some guidelines treat them as equivalent for first-line use.

Kaplan and Sadock's Synopsis of Psychiatry, p. 1259

8. Course and Prognosis

Anxiety disorders are generally chronic, with multiple relapses
GAD: multiple relapses; some relapses occur long after initial episode (giving false sense of recovery)
Panic disorder: ~30-40% symptom-free long term; ~50% mildly symptomatic; ~10-20% severely symptomatic
Good prognostic factors: good premorbid functioning, brief duration of illness, absence of comorbid substance use
Poor prognostic factors: comorbid depression, substance use disorder, personality disorder
All anxiety disorders carry an increased suicide risk - regular monitoring is mandatory

9. Key Rating Scales (Clinical Tools)

Scale	Use
GAD-7	Screening and severity of GAD
Hamilton Anxiety Rating Scale (HAM-A)	Clinician-rated anxiety severity
Beck Anxiety Inventory (BAI)	Patient-rated anxiety severity
Hospital Anxiety and Depression Scale (HADS)	Screens both anxiety and depression
State-Trait Anxiety Inventory (STAI)	Distinguishes situational vs. trait anxiety
Panic Disorder Severity Scale (PDSS)	Monitors panic disorder treatment response

10. Quick Memory Aid - "WATCHME" for Anxiety Exam Points

Letter	Point
W	Worry (GAD = ≥6 months, multiple domains, ≥3/6 symptoms)
A	Amygdala (center of fear neurobiology)
T	Treatment first-line = SSRIs/SNRIs + CBT
C	Chronic course - monitor for relapse and suicide
H	HPA axis dysregulation - link to medical comorbidities
M	Medical causes must be ruled out first
E	Exposure therapy = first-line for specific phobia

Sources:

Kaplan and Sadock's Synopsis of Psychiatry (Anxiety disorders chapter, pp. 624-625, 1249-1269)
Stahl's Essential Psychopharmacology: Neuroscientific Basis (Chapter 8: Anxiety, Trauma, and Treatment, pp. 359-382)
Kaplan & Sadock's Comprehensive Textbook of Psychiatry (Neurobiology chapter)

CN you make a slide presentation on this topic

Reading File

Running Command

mkdir -p /home/daytona/workspace/anxiety-pptx && ls /home/daytona/workspace/anxi…

This is a shared conversation. Sign in to Orris to start your own chat.